The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 16, 2024
Filed:
Jun. 06, 2019
Applicant:
Minoryx Therapeutics S.l., Barcelona, ES;
Inventors:
Marc Martinell Pedemonte, Barcelona, ES;
Maria Pilar Pizcueta Lalanza, Barcelona, ES;
Laura Pilar Rodríguez Pascau, Barcelona, ES;
Assignee:
Minoryx Therapeutics S.L., Mataró, ES;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4439 (2006.01); A61K 9/00 (2006.01); A61P 21/00 (2006.01); A61P 25/28 (2006.01); A61P 27/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4439 (2013.01); A61K 9/0053 (2013.01); A61P 21/00 (2018.01); A61P 25/28 (2018.01); A61P 27/02 (2018.01);
Abstract
The present disclosure relates to a method of treating or preventing mitochondrial diseases by administering 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione or a salt thereof to a subject in need thereof. The disclosure also relates to 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione for use in a pharmaceutical composition or in the manufacture of a medicament for the treatment or prevention of a mitochondrial disease.